NCT06259396

Brief Summary

Bile acid diarrhoea is a common cause of chronic watery diarrhoea. Treatment is life-long medication. However, about 50% of people have ongoing, bothersome diarrhoea. Findings from recent research on diet therapies and food intolerances have been used to develop a healthy dietary pattern called The 8x5 Diet. We will test the practicalities of conducting a randomised controlled trial of this dietary intervention.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 6, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 14, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

April 2, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

December 16, 2024

Status Verified

December 1, 2024

Enrollment Period

12 months

First QC Date

February 6, 2024

Last Update Submit

December 10, 2024

Conditions

Keywords

diet interventionnutritionfeasibilitydiarrhoeaadults

Outcome Measures

Primary Outcomes (6)

  • Consent

    The number (%) of participants who consent to participate in the trial compared to the number (%) that were screened by the research team.

    Recruitment period (50 weeks)

  • Recruitment

    The number (%) of participants randomised compared to the number (%) that were eligible (screened by the research team)

    Recruitment period (50 weeks)

  • Randomisation

    The number (%) of participants who complete their first appointment compared to the number (%) that were randomised, intervention group only.

    Recruitment period (50 weeks)

  • Retention

    Tthe number (%) of participants that completed the study compared to the number (%) randomised to each group.

    Randomisation to trial completion (8 weeks)

  • The trial's data collection instruments and procedures: Missing data

    The number and proportion of missing data identified by the research team from questionnaires.

    At baseline and at Week 8

  • The trial's data collection instruments and procedures: Participants' views and experiences

    Participants' views and experiences of the instruments (questionnaires and diaries) and procedures (screening, randomisation, baseline period, trial, general)

    Study identification to study completion (Week 8)

Study Arms (2)

The 8x5 Diet

ACTIVE COMPARATOR

The 8x5 Diet is a healthy dietary pattern administered virtually by a specialist dietitian

Behavioral: The 8x5 Diet

Control

NO INTERVENTION

Continuation of habitual diet, no dietary changes.

Interventions

The 8x5 DietBEHAVIORAL

A virtual, dietitian-counselled, healthy dietary pattern defined by its fat intake, its daily eating pattern, keeping adequately hydrated, having a variety of whole grains, fruit and vegetables, and use of certain plant fibres.

The 8x5 Diet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years, of any ethnic group, living in the United Kingdom and not planning to move home for the next three months
  • Self-reported diagnosis of bile acid diarrhoea that was confirmed by 7-day SeHCAT testing
  • Self-reported ongoing chronic diarrhoea despite use of appropriate medication
  • Able to participate in either diet group with the intention to remain in the group to which they were assigned for the 8 week study period
  • Body mass index ≥20 kg m-2
  • Able to converse in English (or via their carer, without assistance from an interpreter) using a computer/laptop, smart phone, or tablet
  • Able to provide informed written consent
  • Able to provide the address of their general practioner so that the research team can inform them of their participation.

You may not qualify if:

  • Unable to provide self-reported written confirmation that their diagnosis of bile acid diarrhoea was by SeHCAT testing
  • Pregnant/breastfeeding/planning a pregnancy in the next six months
  • Inflammatory bowel disease, previous or current microscopic colitis, or other serious morbidities such as liver disease, pancreatic disease, AIDS/HIV, radiotherapy for cancer, assessed at screening via patient self-report
  • Diarrhoea that is inadequately active: \<3 stools per day or \<1 watery stool (Bristol Stool Form types 6-7) per day as the mean of one week
  • Currently participating in another research study or has taken part in the previous 3 months
  • If taking insulin, metformin (other than slow-release), anti-obesity medication, or using commercially available formulated supplements to replace meals in previous three months
  • Use of antibiotics in the previous four weeks
  • Food allergies, other than oral allergy syndrome/pollen-food syndrome
  • An eating disorder or disordered eating which is active or in the last 12 months
  • Alcohol or drug abuse, or self-harm, or depression, or suicide ideation in the last 12 months
  • Shift worker
  • If unwilling to keep a weighed 7-day food diary

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yvonne McKenzie

Manchester, Greater Manchester, M13 9PL, United Kingdom

RECRUITING

Related Publications (1)

  • McKenzie YA, Kelman L, O'Connor M, Todd C, Walters JR, Burden S. Diet therapy (The 8x5 Diet) for adults living with bile acid diarrhoea: protocol for a feasibility randomised controlled trial. BMJ Open. 2025 Mar 27;15(3):e097973. doi: 10.1136/bmjopen-2024-097973.

MeSH Terms

Conditions

Diarrhea

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Christopher Todd, Professor

    The University of Manchester

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: feasibility randomised controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Candidate

Study Record Dates

First Submitted

February 6, 2024

First Posted

February 14, 2024

Study Start

April 2, 2024

Primary Completion

March 31, 2025

Study Completion

March 31, 2025

Last Updated

December 16, 2024

Record last verified: 2024-12

Locations